PCT-3010

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePCT-3010
Drug Alias Nameneurological disorders therapeutics (PolyCore Therapeutics)PCT-3010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsCognition DisordersTardive DyskinesiaDyskinesias +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPolyCore Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPolyCore Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCognition DisordersTardive DyskinesiaDyskinesias +[7

Other Information

ATC CodeN/A
Related LinksN/A